Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.12% | 12.63% | 7.17% | 4.07% | 2.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.12% | 12.63% | 7.17% | 4.07% | 2.19% |
| Cost of Revenue | 15.80% | 10.09% | 5.59% | 3.59% | 2.74% |
| Gross Profit | 26.75% | 18.44% | 10.78% | 5.16% | 0.96% |
| SG&A Expenses | 7.97% | 4.14% | 1.14% | 11.41% | -3.76% |
| Depreciation & Amortization | -1.94% | -1.94% | -1.94% | -1.94% | 2.15% |
| Other Operating Expenses | -- | 1,192.92% | -39.05% | -39.05% | -100.00% |
| Total Operating Expenses | 14.52% | 9.37% | 4.61% | 5.34% | 3.07% |
| Operating Income | 86.83% | 61.20% | 48.20% | -11.94% | -9.11% |
| Income Before Tax | 94.82% | 20.11% | -11.34% | -79.81% | -42.33% |
| Income Tax Expenses | 46.73% | 8.54% | -5.21% | -60.40% | -22.05% |
| Earnings from Continuing Operations | 141.54% | 30.53% | -16.05% | -92.59% | -53.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 141.54% | 30.53% | -16.05% | -92.59% | -53.97% |
| EBIT | 86.83% | 61.20% | 48.20% | -11.94% | -9.11% |
| EBITDA | 63.56% | 44.09% | 32.71% | -6.12% | -4.94% |
| EPS Basic | 141.45% | 30.51% | -16.04% | -92.58% | -53.97% |
| Normalized Basic EPS | 140.21% | 58.81% | 25.12% | -61.40% | -29.80% |
| EPS Diluted | 141.82% | 31.21% | -16.42% | -93.03% | -54.21% |
| Normalized Diluted EPS | 139.30% | 58.40% | 24.95% | -61.47% | -29.82% |
| Average Basic Shares Outstanding | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.36% | 0.25% | 0.12% | 0.07% | 0.01% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.59% | -0.23% | 0.19% | 12.50% | 1.17% |